5-Nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, 95.0%, 5g

Ethyl 2-(5,6-dimethyl-4-oxofuro[2,3-d]pyrimidin-3(4H)-yl)acetate, 95%, 500mg

4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine, 95.0%, 10g

Molecular sieve 3 Å, 0.3 nm, type 562 C, bead form, 2.5 kg, plastic packaging.

5-FLUOROQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 250mg

4',6'-Dimethoxy-2'-hydroxyacetophenone>98.0%(GC)5g

N-Methyl-4-pyridylmethylamine, 95.0%, 10g

Methyl 4-methylthiophene-3-carboxylate, 95+%, 5g

4-Amino-8-bromo-2-chloroquinazoline, 95.0%, 10g

1-(4-bromo-2-nitrophenyl)-1,4-diazepane, 95.0%, 5g

Methyl 2-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]sulfanyl}benzoate, 95.0%, 10g

1,3,5-Tris(3-bromophenyl)benzene>96.0%(HPLC)1g

1-hexyl-1,4-diazepane, 95.0%, 2g